On April 23, 2019, Liao Zu Guo resigned as a director and as an officer of Bionovate Technologies Corp. Mr. Guo's resignation was not the result of a disagreement between Mr. Guo and the company on any matter relating to the company's operations, policies or practices. On April 23, 2019, Cohen Mizrahi was appointed as a director to replace Mr. Guo and was also appointed President, Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer of the company.

Dr. Cohen Mizrahi has been working since 2010 as an independent consultant for various medical companies around the Middle East and Asia. His consulting work includes helping companies bring their medical technologies to market and identify business opportunities for undevelopped intellectual property. He took the role of CEO at Bionovate Technologies Corp.

in 2019 and continues his independent work as well.